These data suggest that FcγR3B+ binding may temper the release of inflammatory cytokines that may drive early immune activation and cellular recruitment, potentially contributing to the initiation of the cytokine storm associated with the symptoms of COVID-19 (ref. 70). This evidence concerns the gene FCGR3B and COVID-19.